Disodium cromoglycate inhibits activation of human inflammatory cells in vitro

This publication has 19 references indexed in Scilit:

• DEFECTIVE CHEMOTACTIC FACTOR-INDUCED MONOCYTE COMPLEMENT RECEPTOR ENHANCEMENT IN LUNG-CANCER
  1983
• ENHANCEMENT OF NEUTROPHIL-MEDIATED AND EOSINOPHIL-MEDIATED COMPLEMENT-DEPENDENT KILLING OF SCHISTOSOMULA OF SCHISTOSOMA-MANSONI INVITRO BY LEUKOTRIENE-B4
  1983
• THE EFFECTS OF AN ECF-A AND FORMYL METHIONYL CHEMOTACTIC PEPTIDES ON OXIDATIVE-METABOLISM OF HUMAN EOSINOPHILS AND NEUTROPHILS
  1981
• Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.
  The Journal of Immunology, 1980
• Interactions between human eosinophils and schistosomula of schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence
  The Journal of Experimental Medicine, 1979
• A New Method for the Purification of Human Eosinophils and Neutrophils, and a Comparison of the Ability of These Cells to Damage Schistosomula of Schistosoma Mansoni
  The Journal of Immunology, 1979
• Membrane Receptors for IgG and Complement (C4, C3b and C3d) on Human Eosinophils and Neutrophils and Their Relation to Eosinophilia
  The Journal of Immunology, 1977
• A subpopulation of normal human peripheral B lymphcytes that bind IgE.
  Journal of Clinical Investigation, 1977
• The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.
  The Journal of Experimental Medicine, 1976
• Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen Mechanisms
  Nature, 1967